Targeting Alpha5 Beta1 Integrin to Prevent Metastatic Breast Cancer Cell Invasion: PhScN Target Site Definition and Plasma Stability
Abstract
We proposed to test PHSCN and PhScN derivatives with modifications of the N or Ctermini, and/or cysteine side chain to determine the initial spatial constraints of the binding pocket of the ligand to its target site. This will aid in the selection of crosslinking agents, modifications, tag additions and strategies for determination of the target site(s) performed in Aim 2 and lay the foundation for determining the structure-activity relationships (SARS) of these inhibitors with the target
Document Details
- Document Type
- Technical Report
- Publication Date
- Nov 01, 2015
- Accession Number
- AD1001177
Entities
People
- Philip S. Andrews
Organizations
- Board of Regents of the University of Michigan